Early time of day of administration of immunochemotherapy for enhancing overall survival in patients with lung cancer irrespective of histological type?
Abstract
The striking clinical relevance of the circadian immune system for patients with advanced lung cancer is supported by consistent overall survival prolongation through early time of day of immunochemotherapy, no matter the histological type.
Fields of Study & Subjects
Circadian rhythm and melatonin
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Cancer
- Volume
- 132
- Issue
- 4
- Pages
- e70290–e70290
- Publication date
- 5 February 2026
- Language
- EN